查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球益智藥市場
市場調查報告書
商品編碼
1296863

2023-2030年全球益智藥市場

Global Nootropics Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

在預測期內（2023-2030年），全球益智藥市場預計將以14.1%的年復合成長率成長。對益智藥和聰明藥的需求不斷增加，是推動全球益智藥市場成長的一個關鍵因素。大量的學生和專業人士消費這些聰明藥來提高注意力和記憶力。使用合成和天然原料的持續產品開發預計將推動產品需求。例如，2020年10月，總部設在澳大利亞的益智藥初創公司Neuratech推出了2種針對注意力和壓力的大腦健康補充劑，名為Boost和Calm。 Boost是一種注意力和能量的益智藥，而Calm是一種壓力和睡眠益智藥。此外，由於消費者正在尋求天然營養品，對有機營養品如咖啡和含有天然成分的補充劑的需求激增，如Brahmi、北極根、薑黃、人參和松樹皮。

健身房文化越來越受歡迎，因為在過去10年中，健身房的會員數量增加得更多。因此，性能營養食品，如益智藥，在千禧一代中越來越受歡迎，他們更多的參與到健身活動中。有關益智藥的研究和開發活動數量的增加預計將為市場成長提供有利可圖的機會。然而，與藥物開發和分銷相關的高成本可能會限制市場的成長。在預測期內，與用藥有關的副作用也可能限制市場的成長。

目錄

第一章：報告摘要

  • 當前行業分析和成長潛力展望
  • 研究方法和工具
  • 市場細分
    • 按領域分類
    • 按地區

第二章：市場概述和洞察力

  • 報告的範圍
  • 分析師的洞察力和當前的市場趨勢
    • 主要發現
    • 建議
    • 總結

第三章：競爭格局

  • 主要公司分析
  • Pfizer Inc..
    • 概述
    • 財務分析
    • SWOT分析
    • 近期發展情況
  • GlaxoSmithKline plc
    • 概況
    • 財務分析
    • SWOT分析
    • 近期發展情況
  • Novartis AG
    • 進展概況
    • 財務分析
    • SWOT分析
    • 近期發展
  • 關鍵戰略分析

第四章：市場細分

  • 按形式分類的全球益智藥市場
    • 膠囊/片劑
    • 粉劑
    • 飲料
  • 按配銷通路分類的全球益智藥市場
    • 線下
    • 線上

第五章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第六章：公司簡介

  • AstraZeneca Plc
  • Cephalon A/S
  • GlaxoSmithKline plc
  • Johnson & Johnson Private Ltd.
  • Kimera Koffee
  • Koios Beverage Corp
  • Mental Mojo, LLC
  • Mylan NV
  • Novartis AG
  • Onnit Labs, Inc.
  • Opti-Nutra Ltd.
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC
  • Reckitt Benckiser Group plc
  • Sanofi SA
  • Savvy Beverage
  • Teva Pharmaceutical Industries Ltd.
  • TruBrain Inc.
  • Wolfson Brands (Noocube)
  • Zhou Nutrition LLC
Product Code: OMR2027349

Title: Global Nootropics Market Size, Share & Trends Analysis Report by Form (Capsules/ Tablets, Powder, and Drinks), and by Distribution Channel (Online and Offline) Forecast Period (2023-2030).

The global nootropics market is anticipated to grow at a CAGR of 14.1% during the forecast period (2023-2030). The increasing demand for brain boosters and smart drugs is a key factor driving the growth of the global nootropics market. A large number of students and professionals consume these smart drugs to improve focus and memory. Continuous product development using both synthetic and natural raw materials is anticipated to fuel the product demand. For instance, in October 2020, Australia-based nootropic start-up Neuratech launched 2 brain health supplements for focus and stress, named Boost and Calm. Boost is a focus and energy nootropic, while Calm is a stress and sleep nootropic. Furthermore, the demand for organic nootropics such as coffee and supplements with natural ingredients such as Brahmi, arctic root, turmeric, ginseng, and pine bark witnessed a surge as consumers are seeking natural nootropics products.

Gym cultures is increasingly becoming popular as gym membership have increased with a higher late in last 10 years. Therefore, performance nutrition foods such as nootropics are gaining popularity among millennial are known to be more involved in fitness activates. Increase in the number of research and development activities regarding nootropics is expected to offer lucrative opportunities to the market growth. However, high cost associated with drug development and distribution may restrain the market growth. The side effects linked with administration of nootropics may also restrain the market growth during the forecast period.

Segmental Outlook

The global nootropics market is segmented on the form and distribution channel. Based on the form, the market is sub-segmented into capsules/tablets, powder, and drinks. On the basis of distribution channel, the market is sub-segmented into online and offline. Among the distribution channels, the offline sub-segment is expected to hold a prominent share of the global market, owing to the growing penetration of independent retail companies such as Walmart Tesco, and others. The retail giants further bolster the product visibility and attract a larger consumer base.

Drinks Sub-Segment is Anticipated to hold a Prominent Growth in the Global Nootropics Market

Among the form segment, the drinks sub-segment is expected to hold a prominent growth in the market across the globe. The primary factor supporting the segmental growth includes the rising development and introduction of nootropics or smart drugs in the form of either capsule or tablet. For instance, in January 2020, Sun Chaser, a beverage brand start-up launched pre-orders of their beverages on its official website. The beverage is a carbonated alcohol alternative which does not contain caffeine and booze. Sun Chaser leverages L-theanine and cordyceps for an alcohol alternative. Through this launch, the brand aims to tap into the broad market of functional nootropic ingredients.

Regional Outlook

The global nootropics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the presence of key market players. The rising focus on health along with the rising awareness regarding nootropics is further driving the product demand in this region.

The overall supplements market in North America is growing exponentially, and the use of supplements to enhance the productivity of the brain has helped pave the way for nootropics. Retailers, both online and brick-and-mortar stores, are thereby creating prominent shelf lines for nootropics supplements to cater to the needs of consumers, ranging from teenagers to older adults.

Global Nootropics Market Growth, by Region 2023-2030

Source: OMR Analysis

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Nootropics Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Increasing awareness towards personal health in growing economies such as India & China is one of the key factors driving the growth of the global nootropics market. Chronic diseases such as heart disease, cancer, diabetes, stroke, and arthritis have been on the rise, in recent times. As per the International Diabetes Federation (IDF), around 250 million adults in the age range of 20-79 years were living with diabetes in the region in 2019. These numbers are further expected to rise over a certain period owing to the changing eating habits and more inclination towards unhealthy food diets. The rise in the prevalence of chronic diseases prompts the need for nootropics, which drives the regional growth of the market.

Market Players Outlook

The major companies serving the nootropics market include Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., and Teva Pharmaceutical Industries Ltd. Among others. The market players are considerably contributing to the market growth by the adoption of various strategies including funding for R&D, and new product development, mergers & acquisition, and distribution network expansion among others to remain competitive in the market place. For instance, in October 2022, Shine Drink, Australia's first energy nootropic drink developed with natural nootropics has launched into Woolworths stores nationwide. Additionally, in July 2021, Snack bars was hoping to raise $ 2,48,132 to progress its mission to get true functional nutrition into the hands of the mass market.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global nootropics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Pfizer Inc..
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GlaxoSmithKline plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Novartis AG
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Nootropics Market by Form
    • 4.1.1. Capsules/ Tablets
    • 4.1.2. Powder
    • 4.1.3. Drinks
  • 4.2. Global Nootropics Market by Distribution Channel
    • 4.2.1. Offline
    • 4.2.2. Online

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AstraZeneca Plc
  • 6.2. Cephalon A/S
  • 6.3. GlaxoSmithKline plc
  • 6.4. Johnson & Johnson Private Ltd.
  • 6.5. Kimera Koffee
  • 6.6. Koios Beverage Corp
  • 6.7. Mental Mojo, LLC
  • 6.8. Mylan N.V.
  • 6.9. Novartis AG
  • 6.10. Onnit Labs, Inc.
  • 6.11. Opti-Nutra Ltd.
  • 6.12. Pfizer Inc.
  • 6.13. Reckitt Benckiser Group PLC
  • 6.14. Reckitt Benckiser Group plc
  • 6.15. Sanofi SA
  • 6.16. Savvy Beverage
  • 6.17. Teva Pharmaceutical Industries Ltd.
  • 6.18. TruBrain Inc.
  • 6.19. Wolfson Brands (Noocube)
  • 6.20. Zhou Nutrition LLC

LIST OF TABLES

  • 1. GLOBAL NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
  • 2. GLOBAL NOOTROPICS CAPSULES/ TABLETS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL NOOTROPICS POWDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NOOTROPICS DRINKS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 6. GLOBAL NOOTROPICS IN OFFLINE MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 7. GLOBAL NOOTROPICS IN ONLINE MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 8. GLOBAL NOOTROPICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. NORTH AMERICAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 12. EUROPEAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. EUROPEAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
  • 14. EUROPEAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 15. ASIA- PACIFIC NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. ASIA- PACIFIC NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
  • 17. ASIA- PACIFIC NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 18. REST OF THE WORLD NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NOOTROPICS MARKET SHARE BY FORM, 2022 VS 2030 (%)
  • 2. GLOBAL NOOTROPICS CAPSULES/TABLETS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL NOOTROPICS POWDER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NOOTROPICS DRINKS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL NOOTROPICS MARKET SHARE ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 6. GLOBAL NOOTROPICS IN OFFLINE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL NOOTROPICS IN ONLINE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL NOOTROPICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. US NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 10. CANADA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. UK NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. FRANCE NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. GERMANY NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. ITALY NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. SPAIN NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. REST OF EUROPE NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. INDIA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CHINA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. JAPAN NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SOUTH KOREA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)